ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 39543725

Transcriptome-based network analysis related to regulatory T cells infiltration identified RCN1 as a potential biomarker for prognosis in clear cell renal cell carcinoma.

Qixin Y and 5 others. BioData Min, 2024. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Transcriptome-based network analysis related to regulatory T cells infiltration identified RCN1 as a potential biomarker for prognosis in clear cell renal cell carcinoma. Papers, record 39543725. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39543725

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Transcriptome-based network analysis related to regulatory T cells infiltration identified RCN1 as a potential biomarker for prognosis in clear cell renal cell carcinoma.
PubMed
Journal
BioData Min
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.28, provisional
iCite
Revised in PubMed
2024-11-17
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qixin YYang
2Jing HHuang
3Jiang HHe
4Xueyang LLiu
5Lu YYu
6Yuehua LLi

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125,728,673HSPB1 as a novel regulator of ferroptotic cancer cell death.Oncogene2015https://conductscience.org/library/papers/25728673PubMed
237,990,041The renal cell carcinoma drug market.Nat Rev Drug Discov2024https://conductscience.org/library/papers/37990041PubMed
319,615,940Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.Lancet Oncol2009https://conductscience.org/library/papers/19615940PubMed
428,961,310Treatment of renal cell carcinoma: Current status and future directions.CA Cancer J Clin2017https://conductscience.org/library/papers/28961310PubMed
533,820,997Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment.Nat Med2021https://conductscience.org/library/papers/33820997PubMed
637,723,418Expression signature and prognostic value of CREC gene family in human colorectal cancer.BMC Cancer2023https://conductscience.org/library/papers/37723418PubMed
734,747,128Reticulocalbin 1 is required for proliferation and migration of non-small cell lung cancer cells regulated by osteoblast-conditioned medium.J Cell Mol Med2021https://conductscience.org/library/papers/34747128PubMed
838,057,406RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.Sci Rep2023https://conductscience.org/library/papers/38057406PubMed
937,175,653The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.Int J Mol Sci2023https://conductscience.org/library/papers/37175653PubMed
1023,990,412Bayesian consensus clustering.Bioinformatics2013https://conductscience.org/library/papers/23990412PubMed

1 to 10 of 58

See all 58 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41,035,074Single-cell sequencing technology in renal cancer: insights into tumor biology and clinical application.Biomark Res2025https://conductscience.org/library/papers/41035074PubMed
40,975,763Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target.BMC Cancer2025https://conductscience.org/library/papers/40975763PubMed
40,808,964Comprehensive analysis of regulatory B Cell related genes in prognosis and therapeutic response in lung adenocarcinoma.Front Immunol2025https://conductscience.org/library/papers/40808964PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
RCN15,954PubTator's text mininghttps://conductscience.org/library/genes/5954

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39543725

GET https://conductscience.org/api/papers/v1/39543725/references?page=2

API referenceFor AI assistants